GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33897
Submission : 2019-05-31
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33897
Submission : 2019-05-31
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE
Drug : NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
Dosage Form : CAPSULE; ORAL
Application Number : 202250
Country : US
Patented : No
Drug : METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 79118
Country : US
Patented : No
Drug : CLINDAGEL
Dosage Form : GEL; TOPICAL
Application Number : 50782
Country : US
Patented : No
Drug : DIFFERIN
Dosage Form : LOTION; TOPICAL
Application Number : 22502
Country : US
Patented : Yes
Drug : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 204452
Country : US
Patented : No
Drug : DIETHYLPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 91680
Country : US
Patented : No
Drug : DESONATE
Dosage Form : GEL; TOPICAL
Application Number : 21844
Country : US
Patented : No
Drug : SILDENAFIL CITRATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 215708
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
LOOKING FOR A SUPPLIER?